The effect of motivational interviewing–based health behavior counseling on lipid control among patients with hyperlipidemia

Authors

  • Butchaya Sansee Social Medicine Department, Nakornping Hospital

Keywords:

motivational interviewing, hyperlipidemia, lipid control, cardiovascular risk

Abstract

Introduction: Hyperlipidemia is a major modifiable risk factor, and behavioral modification is essential in its management. Motivational interviewing (MI) has been shown in several studies to improve lipid control and reduce cardiovascular disease risk. However, evidence in the context of primary care in Thailand remains limited.

Objective: To evaluate the effect of motivational interviewing–based health behavior counseling, compared with standard care, on changes in blood lipid levels and cardiovascular risk scores among participants.

Methods: A prospective, non-randomize systematic allocation trial was conducted among patients who had abnormal lipid profiles or were at high risk for cardiovascular events attending the Family Medicine Outpatient Department at Nakornping Hospital between 2024 and 2025. The intervention group received motivational interviewing sessions, whereas the control group received standard care. Both groups were followed up at 3 months. Differences in means or proportions between and within groups were analyzed using multiple logistic regression, adjusting for important covariates.

Results: A total of 50 patients were enrolled, with 25 patients allocated to the intervention group (male 36%, mean age 59.44 ± 11.97 years) and 25 patients to the control group (male 36%, mean age 65.40 ± 9.83 years). After 3-month follow-up, both groups showed statistically significant reductions in mean total cholesterol and LDL‑cholesterol levels compared with baseline. The mean changes in total cholesterol were -21.24 mg/dL (95% CI -44.10 to 1.62) in the intervention group and -7.88 mg/dL (95% CI -25.94 to 10.18) in the control group, while the corresponding changes in LDL-cholesterol were -25.12 mg/dL (95% CI -49.54 to -0.70) and -7.56 mg/dL (95% CI -26.05 to 10.93), respectively. However, multivariable logistic regression adjusting for baseline characteristics demonstrated no statistically significant differences between groups. Triglycerides, HDL‑cholesterol, and cardiovascular risk scores tended to improve in both groups, but these changes did not reach statistical significance. In contrast, the intervention group showed a significantly greater increase in knowledge and awareness scores than the control group (mean difference 4.16, 95% CI 3.28–5.04, p < 0.001).

Conclusion: Motivational interviewing helped reduce LDL cholesterol and showed a trend toward improving overall lipid profiles, despite no significant differences in other indicators. Integrating this technique with standard care may support better lipid control and lower long term cardiovascular risk.

References

World Heart Federation. World Heart Report 2023: Confronting the world’s number one killer [Internet]. Geneva: World Heart Federation; c2023. Available from: https://world-heart-federation.org/wp-content/uploads/World-Heart-Report-2023.pdf

Di Cesare M, Perel P, Taylor S, Kabudula C, Bixby H, Gaziano TA, et al. The Heart of the World. Glob Heart. 2024;19(1):11. doi: 10.5334/gh.1288.

British Heart Federation. Global heart & circulatory diseases factsheet 2023 [Internet]. United Kingdom: British Heart Federation; c2023 [updated 2023 June]. Available from: https://share.google/oCEjnFnNMkQsTU4yA

World Heart Federation. Thailand – World Heart Observatory country profile 2021 [Internet]. Geneva: World Heart Federation; c2021. Available from: https://world-heart-federation.org/world-heart-observatory/countries/thailand/

International Trade Administration. Thailand healthcare: Non-communicable diseases [Internet]. Washington, DC: International Trade Administration; c2025 [updated 2025 Sep 4]. Available from: https://www.trade.gov/market-intelligence/ thailand-healthcare-non-communicable-diseases

Abate SM, Thanigaimani S, Sinha M, Sun D, Golledge J. A systematic review and meta-analysis testing the effect of lifestyle modification and medication optimization programs on cholesterol and blood pressure in patients with cardiovascular disease. Syst Rev. 2025;14(1):153. doi: 10.1186/s13643-025-02857-5.

Demissie GD, Birungi J, Shrestha A, Haregu T, Thirunavukkarasu S, Oldenburg B. The effectiveness of lifestyle interventions in reducing cardiovascular risk and risk factors in people with prediabetes: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2025;35(10):104130. doi: 10.1016/j.numecd.2025.104130.

Mifsud JL, Galea J, Garside J, Stephenson J, Astin F. Motivational interviewing to support modifiable risk factor change in individuals at increased risk of cardiovascular disease: A systematic review and meta-analysis. PLoS One. 2020;15(11):e0241193. doi: 10.1371/journal.pone.0241193.

Bóveda-Fontán J, Barragán-Brun N, Campiñez-Navarro M, Pérula-de Torres LÁ, Bosch-Fontcuberta JM, Martín-Álvarez R, et al. Effectiveness of motivational interviewing in patients with dyslipidemia: a randomized cluster trial. BMC Fam Pract. 2015;16:151. doi: 10.1186/s12875-015-0370-2.

Lolekha P, Khovidhunkit W, Deerochanawong C, Thongtang N, Boonyasirinant T, Rattarasarn C, et al. 2024 The Royal College of Physicians of Thailand (RCPT) clinical practice guidelines on management of dyslipidemia for atherosclerotic cardiovascular disease prevention. Asian Biomed (Res Rev News). 2024;18(6):246-67. doi: 10.2478/abm-2024-0033.

Mahidol University Faculty of Medicine Ramathibodi Hospital, Office of the Higher Education Commission, The Thailand Research Fund, Health Systems Research Institute, Electricity Generating Authority of Thailand, The Heart Association of Thailand under the Royal Patronage of H.M. The King, et al. Thai CV risk score [Internet]. Bangkok: Mahidol University Faculty of Medicine Ramathibodi Hospital [cited 2026 Jan 29]. Available from: https://www.rama.mahidol.ac.th/cardio_vascular_risk/thai_cv_risk_score/ [In Thai]

Boulmpou A, Kartas A, Farmakis I, Zafeiropoulos S, Nevras V, Papadimitriou I, et al. Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design. Hellenic J Cardiol. 2019;60(4):249-53. doi: 10.1016/j.hjc.2018.10.002.

Palacio A, Garay D, Langer B, Taylor J, Wood BA, Tamariz L. Motivational Interviewing Improves Medication Adherence: a Systematic Review and Meta-analysis. J Gen Intern Med. 2016;31(8):929-40. doi: 10.1007/s11606-016-3685-3.

Suttipong C. Group Motivational Interviewing technique result to Hemoglobin A1c and Glomerular filtration rate in diabetic patients. Journal of Nakornping Hospital. 2022;13(1):128-42. [In Thai]

Downloads

Published

14-03-2026

How to Cite

Sansee, B. (2026). The effect of motivational interviewing–based health behavior counseling on lipid control among patients with hyperlipidemia. Journal of Nakornping Hospital, 17(2), 199–209. retrieved from https://he01.tci-thaijo.org/index.php/jnkp/article/view/284407

Issue

Section

Research article